Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network (Q47258226)

12 January 2018

title

Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network (English)

1 reference

12 January 2018

artificial neural network

main subject

schizophrenia

0 references

patient

0 references

0 references

author

Stephan Arndt

5

1 reference

12 January 2018

author name string

Corson PW

1

1 reference

12 January 2018

Nopoulos P

2

1 reference

12 January 2018

Andreasen NC

3

1 reference

12 January 2018

Heckel D

4

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 September 1999

1 reference

12 January 2018

published in

Biological Psychiatry

1 reference

12 January 2018

volume

46

1 reference

12 January 2018

page(s)

712-720

1 reference

12 January 2018

issue

5

1 reference

12 January 2018

describes a project that uses

artificial neural network

1 reference

based on heuristic

inferred from title

cites work

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Image processing for the study of brain structure and function: problems and programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Problems with ratio and proportion measures of imaged cerebral structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Longitudinal change in basal ganglia volume in patients with Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Positron emission tomographic scan investigations of Huntington's disease: cerebral metabolic correlates of cognitive function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Caudate nucleus area in drug-induced parkinsonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Structural abnormalities in deficit and nondeficit schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Schizophrenia, psychosis, and the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Parkinsonism in neuroleptic-naive schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Neuroleptic treatment and caudate plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Basal ganglia pathology in schizophrenia and tardive dyskinesia: an MRI quantitative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

The basal ganglia and cognitive pattern generators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Caudate, putamen, and globus pallidus volume in schizophrenia: a quantitative MRI study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Neurochemical architecture of the human striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Attention deficit-hyperactivity disorder and asymmetry of the caudate nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Changes in caudate volume with neuroleptic treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Neuropsychiatric implications of basal ganglia dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Measurement of brain structures with artificial neural networks: two- and three-dimensional applications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Risperidone in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Magnetic resonance imaging measurement of the caudate nucleus in adolescents with attention-deficit hyperactivity disorder and its relationship with neuropsychological and behavioral measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

A decrease in the size of the basal ganglia in children with fetal alcohol syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Neurobehavioral changes associated with caudate lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Perceptual capacity, functions of the corpus striatum and schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

MRI abnormalities in tardive dyskinesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Limbic selectivity of clozapine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Reduced caudate nucleus volume in obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Increased right caudate nucleus size in obsessive-compulsive disorder: detection with magnetic resonance imaging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Human striatum: chemoarchitecture of the caudate nucleus, putamen and ventral striatum in health and Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Magnetic resonance brain imaging in women with obsessive-compulsive disorder and trichotillomania.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

A magnetic resonance imaging study of schizophrenia: brain structure and clinical symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

"Perestroika" in the basal forebrain: opening the border between neurology and psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900079-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00079-7

1 reference

12 January 2018

PubMed ID

10472424

1 reference

12 January 2018